MedTrace Logo

Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity

NCT01888315 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2013-06-27

No results posted yet for this study

Summary

The study is aiming to document the long-term safety and effectiveness of renal denervation in patients with hypertension and other diseases characterized by elevated sympathetic drive. Catheter-based renal denervation will be performed using CE marked, percutaneous, systems.

Conditions

Interventions

DEVICE

Renal denervation with Symplicity Flex Medtronic/Ardian

Renal denervation using CE-marked devices will be performed according to best medical practice.

DEVICE

Renal denervation with EnligHTN St. Jude Medical

Renal denervation using CE-marked devices will be performed according to best medical practice.

DEVICE

Renal denervation with Paradise Recor

Renal denervation using CE-marked devices will be performed according to best medical practice.

DEVICE

Renal denervation with V2 Vessix

Renal denervation using CE-marked devices will be performed according to best medical practice.

Sponsors & Collaborators

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Felix Mahfoud, MD · University Hospital, Saarland

  • Michael Böhm, MD · University Hospital, Saarland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01888315 on ClinicalTrials.gov